Quality of Life in Psoriasis: A Cross-Sectional Study from North India

Overview

Journal Indian J Dermatol

Specialty Dermatology

Date 2024 Apr 4

PMID 38572024

Authors

Khushboo Arora

Neirita Hazarika

Ranjeeta Kumari

Himanshu Chawla

Affiliations

Soon will be listed here.

Abstract

Background: Psoriasis is a chronic inflammatory papulo-squamous disease characterized by multiple remissions and relapses. This study aimed to assess the impact of psoriasis on the quality of life of patients.

Materials And Methods: A hospital-based, cross-sectional study was conducted enrolling 198 adult patients of psoriasis. The STROBE (Strengthening the Reporting of Observational Studies in Epidemiology) guidelines for observational studies were followed. Clinical severity of psoriasis was measured using Psoriasis Area Severity Index (PASI), and quality of life was measured by EuroQoL 5D (EQ-5D-5L, EQ-VAS) and Psoriasis Quality-Of-Life-12 (PQOL-12) Questionniares.

Results: Of the 198 patients, 71.7% ( = 142/198) were males with a mean age of 41.65 ± 13.19 years. The mean PASI score was 12.46 ± 11.51, and the mean PQOL-12 score was 50.18 ± 23.36. Up to 22.7% ( = 45) cases had 'severe' and 6.1% ( = 12) cases has 'very severe' PQOL-12 scores. Statistically significant correlation ( < 0.05) was observed between PASI scores and almost all domains of EQ-5D-5L and PQOL-12.

Conclusion: Psoriasis affects most psycho-social domains of a patient's life. Coping with these QOL issues remains a challenge to the patients in everyday life. The goal of management of psoriasis therefore must include measures to improve quality of life along with long-lasting remittance of physical symptoms.

References

Connor C, Liu V, Fiedorowicz J . Exploring the Physiological Link between Psoriasis and Mood Disorders. Dermatol Res Pract. 2015; 2015:409637. PMC: 4624926. DOI: 10.1155/2015/409637. View

Rakhesh S, DSouza M, Sahai A . Quality of life in psoriasis: a study from south India. Indian J Dermatol Venereol Leprol. 2009; 74(6):600-6. DOI: 10.4103/0378-6323.45101. View

Revicki D, Osoba D, Fairclough D, Barofsky I, BERZON R, Leidy N . Recommendations on health-related quality of life research to support labeling and promotional claims in the United States. Qual Life Res. 2001; 9(8):887-900. DOI: 10.1023/a:1008996223999. View

Al-Mazeedi K, El-Shazly M, Al-Ajmi H . Impact of psoriasis on quality of life in Kuwait. Int J Dermatol. 2006; 45(4):418-24. DOI: 10.1111/j.1365-4632.2006.02502.x. View

Nayak P, Girisha B, Noronha T . Correlation between Disease Severity, Family Income, and Quality of Life in Psoriasis: A Study from South India. Indian Dermatol Online J. 2018; 9(3):165-169. PMC: 5956862. DOI: 10.4103/idoj.IDOJ_250_17. View

Heredi E, Rencz F, Balogh O, Gulacsi L, Herszenyi K, Hollo P . Exploring the relationship between EQ-5D, DLQI and PASI, and mapping EQ-5D utilities: a cross-sectional study in psoriasis from Hungary. Eur J Health Econ. 2014; 15 Suppl 1:S111-9. DOI: 10.1007/s10198-014-0600-x. View

Ljosaa T, Rustoen T, Mork C, Stubhaug A, Miaskowski C, Paul S . Skin pain and discomfort in psoriasis: an exploratory study of symptom prevalence and characteristics. Acta Derm Venereol. 2010; 90(1):39-45. DOI: 10.2340/00015555-0764. View

Jacobson C, Kimball A . Rethinking the Psoriasis Area and Severity Index: the impact of area should be increased. Br J Dermatol. 2004; 151(2):381-7. DOI: 10.1111/j.1365-2133.2004.06035.x. View

Shankar V, Ghosh S, Ghosh K, Chaudhuri U . Pasi and pqol-12 score in psoriasis: is there any correlation?. Indian J Dermatol. 2011; 56(3):287-9. PMC: 3132905. DOI: 10.4103/0019-5154.82482. View

10.

de Korte J, Sprangers M, Mombers F, Bos J . Quality of life in patients with psoriasis: a systematic literature review. J Investig Dermatol Symp Proc. 2004; 9(2):140-7. DOI: 10.1046/j.1087-0024.2003.09110.x. View

11.

Sarkar R, Chugh S, Bansal S . General measures and quality of life issues in psoriasis. Indian Dermatol Online J. 2016; 7(6):481-488. PMC: 5134161. DOI: 10.4103/2229-5178.193908. View

12.

Krueger G, Koo J, Lebwohl M, Menter A, Stern R, Rolstad T . The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey. Arch Dermatol. 2001; 137(3):280-4. View

13.

Mahajan R, Handa S . Pathophysiology of psoriasis. Indian J Dermatol Venereol Leprol. 2013; 79 Suppl 7:S1-9. DOI: 10.4103/0378-6323.115505. View

14.

Chung J, Callis Duffin K, Takeshita J, Shin D, Krueger G, Robertson A . Palmoplantar psoriasis is associated with greater impairment of health-related quality of life compared with moderate to severe plaque psoriasis. J Am Acad Dermatol. 2014; 71(4):623-32. PMC: 4165651. DOI: 10.1016/j.jaad.2014.04.063. View

15.

Finlay A, Kelly S . Psoriasis--an index of disability. Clin Exp Dermatol. 1987; 12(1):8-11. DOI: 10.1111/j.1365-2230.1987.tb01844.x. View

16.

Roque Ferreira B, Pio-Abreu J, Reis J, Figueiredo A . Analysis of the Prevalence of Mental Disorders in Psoriasis: The Relevance of Psychiatric Assessment in Dermatology. Psychiatr Danub. 2017; 29(4):401-406. DOI: 10.24869/psyd.2017.401. View

17.

. EuroQol--a new facility for the measurement of health-related quality of life. Health Policy. 1990; 16(3):199-208. DOI: 10.1016/0168-8510(90)90421-9. View